Type-I organic photosensitizers with two complementary reactive oxygen species based on donor-acceptor (D-A) molecules
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Good steel used in the blade: well-tailored type-I photosensitizers with aggregation-induced emission characteristics for precise nuclear targeting photodynamic therapy10.1002/advs.202100524 ↗
2. Cancer-cell-activated in situ synthesis of mitochondria-targeting AIE photosensitizer for precise photodynamic therapy10.1002/anie.202017350 ↗
3. The concept and examples of type-III photosensitizers for cancer photodynamic therapy10.1016/j.chempr.2021.10.006 ↗
4. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
5. How does photodynamic therapy work?10.1111/j.1751-1097.1992.tb04222.x ↗
6. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
7. Photophysics and photochemistry of photodynamic therapy: fundamental aspects10.1007/s10103-008-0539-1 ↗
8. Cell death pathways in photodynamic therapy of cancer10.3390/cancers3022516 ↗
9. Reactive oxygen species (ROS)-Based nanomedicine10.1021/acs.chemrev.8b00626 ↗
10. A feasible strategy of fabricating type I photosensitizer for photodynamic therapy in cancer cells and pathogens10.1021/acsnano.1c01577 ↗
11. Unimolecular photodynamic O2-economizer to overcome hypoxia resistance in phototherapeutics10.1021/jacs.0c00734 ↗
12. Design of pluronic-based formulation for enhanced redaporfin-photodynamic therapy against pigmented melanoma10.1021/acsami.6b07031 ↗
13. Upconversion nanoparticle-induced multimode photodynamic therapy based on a metal-organic framework/titanium dioxide nanocomposite10.1021/acsami.0c01467 ↗
14. Cascade reactions by nitric oxide and hydrogen radical for anti-hypoxia photodynamic therapy using an activatable photosensitizer10.1021/jacs.0c10517 ↗
15. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
16. Endoplasmic reticulum-localized iridium(III) complexes as efficient photodynamic therapy agents via protein modifications10.1021/jacs.6b05302 ↗
17. Restricting bond rotations by ring fusion: a novel molecular design strategy to improve photodynamic antibacterial efficacy of AIE photosensitizers10.1021/acsami.1c24329 ↗
18. Long-wavelength AIE-based fluorescent probes for mitochondria-targeted imaging and photodynamic therapy of hepatoma cells10.1021/acsabm.1c00673 ↗
19. Metabolic competition in the tumor microenvironment is a driver of cancer progression10.1016/j.cell.2015.08.016 ↗
20. Chemical design and synthesis of functionalized probes for imaging and treating tumor hypoxia10.1021/acs.chemrev.6b00525 ↗
21. Near-infrared upconversion mesoporous cerium oxide hollow biophotocatalyst for concurrent pH-/H2O2 -responsive O2 -evolving synergetic cancer therapy10.1002/adma.201704833 ↗
22. Superoxide radical photogenerator with amplification effect: surmounting the achilles' heels of photodynamic oncotherapy10.1021/jacs.8b13141 ↗
23. Molecular engineering to boost AIE‐active free radical photogenerators and enable high‐performance photodynamic therapy under hypoxia10.1002/adfm.202002057 ↗
24. Precise molecular engineering of type I photosensitizers with near-infrared aggregation-induced emission for image-guided photodynamic killing of multidrug-resistant bacteria10.1002/advs.202104079 ↗
25. Type I photosensitizers revitalizing photodynamic oncotherapy
26. Aggregation‐enhanced theranostics: AIE sparkles in biomedical field10.1002/agt2.7 ↗
27. Precise and long-term tracking of adipose-derived stem cells and their regenerative capacity via superb bright and stable organic nanodots10.1021/nn505554y ↗
28. Long wavelength excitable near-infrared fluorescent nanoparticles with aggregation-induced emission characteristics for image-guided tumor resection10.1039/C6SC04384D ↗
29. Aggregation-induced emission (AIE) dots: emerging theranostic nanolights10.1021/acs.accounts.8b00060 ↗
30. 9,10-Phenanthrenequinone: a promising kernel to develop multifunctional antitumor systems for efficient type I photodynamic and photothermal synergistic therapy10.1021/acsnano.1c07730 ↗
31. A highly efficient and photostable photosensitizer with near-infrared aggregation-induced emission for image-guided photodynamic anticancer therapy10.1002/adma.201700548 ↗
32. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect10.1016/j.addr.2010.04.009 ↗
33. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?10.7150/thno.7193 ↗
34. O2-Generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia10.7150/thno.22465 ↗
35. An NIR-II-emissive photosensitizer for hypoxia-tolerant photodynamic theranostics10.1002/adma.202003471 ↗